img

Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tumor Necrosis Factor Receptor Superfamily Member 1A report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tumor Necrosis Factor Receptor Superfamily Member 1A market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Genital Warts and Melanoma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tumor Necrosis Factor Receptor Superfamily Member 1A industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tumor Necrosis Factor Receptor Superfamily Member 1A key manufacturers include Addex Therapeutics Ltd, G&E Herbal Biotechnology Co., Ltd., GlaxoSmithKline Plc, Inflamalps SA and Polaris Pharmaceuticals, Inc., etc. Addex Therapeutics Ltd, G&E Herbal Biotechnology Co., Ltd., GlaxoSmithKline Plc are top 3 players and held % sales share in total in 2022.
Tumor Necrosis Factor Receptor Superfamily Member 1A can be divided into LY-3232094, EYS-606, SRT-100 and Others, etc. LY-3232094 is the mainstream product in the market, accounting for % sales share globally in 2022.
Tumor Necrosis Factor Receptor Superfamily Member 1A is widely used in various fields, such as Genital Warts, Melanoma, Multiple Sclerosis and Psoriasis, etc. Genital Warts provides greatest supports to the Tumor Necrosis Factor Receptor Superfamily Member 1A industry development. In 2022, global % sales of Tumor Necrosis Factor Receptor Superfamily Member 1A went into Genital Warts filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tumor Necrosis Factor Receptor Superfamily Member 1A market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Addex Therapeutics Ltd
G&E Herbal Biotechnology Co., Ltd.
GlaxoSmithKline Plc
Inflamalps SA
Polaris Pharmaceuticals, Inc.
Segment by Type
LY-3232094
EYS-606
SRT-100
Others

Segment by Application


Genital Warts
Melanoma
Multiple Sclerosis
Psoriasis
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Tumor Necrosis Factor Receptor Superfamily Member 1A market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tumor Necrosis Factor Receptor Superfamily Member 1A, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tumor Necrosis Factor Receptor Superfamily Member 1A industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tumor Necrosis Factor Receptor Superfamily Member 1A in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tumor Necrosis Factor Receptor Superfamily Member 1A introduction, etc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Tumor Necrosis Factor Receptor Superfamily Member 1A market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Overview
1.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Product Overview
1.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Segment by Type
1.2.1 LY-3232094
1.2.2 EYS-606
1.2.3 SRT-100
1.2.4 Others
1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Type
1.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Overview by Type (2018-2034)
1.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size Review by Type (2018-2024)
1.3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Type (2018-2024)
1.4.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Type (2018-2024)
2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Competition by Company
2.1 Global Top Players by Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (2018-2024)
2.2 Global Top Players by Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (2018-2024)
2.3 Global Top Players by Tumor Necrosis Factor Receptor Superfamily Member 1A Price (2018-2024)
2.4 Global Top Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Competitive Situation and Trends
2.5.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tumor Necrosis Factor Receptor Superfamily Member 1A Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A as of 2022)
2.7 Date of Key Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 1A Market
2.8 Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 1A Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tumor Necrosis Factor Receptor Superfamily Member 1A Status and Outlook by Region
3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size by Region
3.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Region (2018-2024)
3.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Region (2018-2024)
3.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Region
3.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Region (2024-2034)
3.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Region (2024-2034)
3.3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Tumor Necrosis Factor Receptor Superfamily Member 1A by Application
4.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Segment by Application
4.1.1 Genital Warts
4.1.2 Melanoma
4.1.3 Multiple Sclerosis
4.1.4 Psoriasis
4.1.5 Others
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Application
4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Overview by Application (2018-2034)
4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size Review by Application (2018-2024)
4.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Application (2018-2024)
4.3.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Breakdown by Application (2018-2024)
5 North America Tumor Necrosis Factor Receptor Superfamily Member 1A by Country
5.1 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size by Country
5.1.1 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2018-2024)
5.1.3 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2018-2024)
5.2 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Country
5.2.1 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2024-2034)
5.2.2 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2024-2034)
6 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A by Country
6.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size by Country
6.1.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2018-2024)
6.1.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2018-2024)
6.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Country
6.2.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2024-2034)
6.2.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2024-2034)
7 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A by Region
7.1 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size by Region
7.1.1 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Region
7.2.1 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Region (2024-2034)
8 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A by Country
8.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size by Country
8.1.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2018-2024)
8.1.3 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2018-2024)
8.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Country
8.2.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2024-2034)
8.2.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2024-2034)
9 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A by Country
9.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Size by Country
9.1.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Forecasted Market Size by Country
9.2.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Addex Therapeutics Ltd
10.1.1 Addex Therapeutics Ltd Company Information
10.1.2 Addex Therapeutics Ltd Introduction and Business Overview
10.1.3 Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
10.1.5 Addex Therapeutics Ltd Recent Development
10.2 G&E Herbal Biotechnology Co., Ltd.
10.2.1 G&E Herbal Biotechnology Co., Ltd. Company Information
10.2.2 G&E Herbal Biotechnology Co., Ltd. Introduction and Business Overview
10.2.3 G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2018-2024)
10.2.4 G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
10.2.5 G&E Herbal Biotechnology Co., Ltd. Recent Development
10.3 GlaxoSmithKline Plc
10.3.1 GlaxoSmithKline Plc Company Information
10.3.2 GlaxoSmithKline Plc Introduction and Business Overview
10.3.3 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
10.3.5 GlaxoSmithKline Plc Recent Development
10.4 Inflamalps SA
10.4.1 Inflamalps SA Company Information
10.4.2 Inflamalps SA Introduction and Business Overview
10.4.3 Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
10.4.5 Inflamalps SA Recent Development
10.5 Polaris Pharmaceuticals, Inc.
10.5.1 Polaris Pharmaceuticals, Inc. Company Information
10.5.2 Polaris Pharmaceuticals, Inc. Introduction and Business Overview
10.5.3 Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
10.5.5 Polaris Pharmaceuticals, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Industrial Chain Analysis
11.4 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Dynamics
11.4.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Industry Trends
11.4.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Drivers
11.4.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Challenges
11.4.4 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Distributors
12.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of LY-3232094
Table 2. Major Company of EYS-606
Table 3. Major Company of SRT-100
Table 4. Major Company of Others
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (K Units)
Table 7. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (US& Million)
Table 9. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share in Value by Type (2018-2024)
Table 10. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2024-2034) & (K Units)
Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type (2024-2034)
Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (K Units)
Table 17. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2018-2024)
Table 19. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2018-2024)
Table 23. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Company (2018-2024) & (K Units)
Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Company (2018-2024)
Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Company (2018-2024)
Table 30. Global Market Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A as of 2022)
Table 34. Date of Key Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 1A Market
Table 35. Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 1A Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2018-2024) & (K Units)
Table 39. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Region (2018-2024)
Table 42. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2024-2034) & (K Units)
Table 44. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Region (2024-2034)
Table 47. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) & (K Units)
Table 50. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application (2018-2024)
Table 53. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2024-2034) & (K Units)
Table 55. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application (2024-2034)
Table 58. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) (K Units)
Table 60. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) (K Units)
Table 62. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) (K Units)
Table 66. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (K Units)
Table 70. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2018-2024)
Table 73. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (K Units)
Table 74. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (K Units)
Table 78. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (K Units)
Table 82. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Country (2024-2034)
Table 109. Addex Therapeutics Ltd Company Information
Table 110. Addex Therapeutics Ltd Introduction and Business Overview
Table 111. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 113. Addex Therapeutics Ltd Recent Development
Table 114. G&E Herbal Biotechnology Co., Ltd. Company Information
Table 115. G&E Herbal Biotechnology Co., Ltd. Introduction and Business Overview
Table 116. G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 118. G&E Herbal Biotechnology Co., Ltd. Recent Development
Table 119. GlaxoSmithKline Plc Company Information
Table 120. GlaxoSmithKline Plc Introduction and Business Overview
Table 121. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 123. GlaxoSmithKline Plc Recent Development
Table 124. Inflamalps SA Company Information
Table 125. Inflamalps SA Introduction and Business Overview
Table 126. Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 128. Inflamalps SA Recent Development
Table 129. Polaris Pharmaceuticals, Inc. Company Information
Table 130. Polaris Pharmaceuticals, Inc. Introduction and Business Overview
Table 131. Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 133. Polaris Pharmaceuticals, Inc. Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Trends
Table 137. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Drivers
Table 138. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Challenges
Table 139. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Restraints
Table 140. Tumor Necrosis Factor Receptor Superfamily Member 1A Distributors List
Table 141. Tumor Necrosis Factor Receptor Superfamily Member 1A Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 1A Product Picture
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of LY-3232094
Figure 6. Global LY-3232094 Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of EYS-606
Figure 8. Global EYS-606 Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of SRT-100
Figure 10. Global SRT-100 Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2022 & 2034
Figure 15. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type in 2022
Figure 16. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type in 2022
Figure 17. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type in 2022
Figure 18. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type in 2022
Figure 21. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue in 2022
Figure 27. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Genital Warts
Figure 29. Global Genital Warts Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Melanoma
Figure 31. Global Melanoma Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Multiple Sclerosis
Figure 33. Global Multiple Sclerosis Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Psoriasis
Figure 35. Global Psoriasis Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application in 2022 & 2034
Figure 40. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application in 2022
Figure 41. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application in 2022
Figure 42. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application in 2022
Figure 43. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application in 2022
Figure 46. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturing Cost Structure
Figure 51. Tumor Necrosis Factor Receptor Superfamily Member 1A Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed